Diego Ardigò

3.1k total citations
58 papers, 2.1k citations indexed

About

Diego Ardigò is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Diego Ardigò has authored 58 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 18 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Physiology. Recurrent topics in Diego Ardigò's work include Adipokines, Inflammation, and Metabolic Diseases (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Nutritional Studies and Diet (6 papers). Diego Ardigò is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers) and Nutritional Studies and Diet (6 papers). Diego Ardigò collaborates with scholars based in Italy, United States and France. Diego Ardigò's co-authors include Ivana Zavaroni, Silvia Valtueña, Laura Franzini, Furio Brighenti, Daniele Del Rio, Nicoletta Pellegrini, PierMarco Piatti, Eleni I. Georga, Dimitrios I. Fotiadis and Vasilios C. Protopappas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bioinformatics and PLoS ONE.

In The Last Decade

Diego Ardigò

57 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diego Ardigò Italy 28 548 382 380 377 374 58 2.1k
Jean‐Louis Paul France 26 364 0.7× 758 2.0× 227 0.6× 143 0.4× 208 0.6× 75 2.1k
Kyung‐Soo Kim South Korea 27 646 1.2× 624 1.6× 397 1.0× 176 0.5× 336 0.9× 119 2.6k
Rosaria Vincenza Giglio Italy 30 701 1.3× 582 1.5× 338 0.9× 156 0.4× 176 0.5× 91 2.5k
Viviane Zorzanelli Rocha Brazil 15 359 0.7× 494 1.3× 321 0.8× 119 0.3× 514 1.4× 36 2.2k
Shanil Juma United States 22 493 0.9× 604 1.6× 240 0.6× 166 0.4× 128 0.3× 49 2.3k
Donatella Siepi Italy 25 529 1.0× 309 0.8× 344 0.9× 102 0.3× 671 1.8× 70 1.9k
Michal Vráblík Czechia 26 501 0.9× 343 0.9× 171 0.5× 157 0.4× 387 1.0× 167 2.0k
Parakat Vijayagopal United States 26 345 0.6× 944 2.5× 225 0.6× 101 0.3× 248 0.7× 78 2.6k
Mariana Floria Romania 18 347 0.6× 525 1.4× 300 0.8× 167 0.4× 465 1.2× 99 1.9k
Manuela Ciocoiu Romania 17 358 0.7× 549 1.4× 258 0.7× 66 0.2× 204 0.5× 98 1.7k

Countries citing papers authored by Diego Ardigò

Since Specialization
Citations

This map shows the geographic impact of Diego Ardigò's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Ardigò with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Ardigò more than expected).

Fields of papers citing papers by Diego Ardigò

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Ardigò. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Ardigò. The network helps show where Diego Ardigò may publish in the future.

Co-authorship network of co-authors of Diego Ardigò

This figure shows the co-authorship network connecting the top 25 collaborators of Diego Ardigò. A scholar is included among the top collaborators of Diego Ardigò based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Ardigò. Diego Ardigò is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jonker, Anneliene Hechtelt, et al.. (2023). How to START? Four pillars to optimally begin your orphan drug development. Orphanet Journal of Rare Diseases. 18(1). 229–229. 2 indexed citations
3.
Zanello, Galliano, et al.. (2023). Sustainable approaches for drug repurposing in rare diseases: recommendations from the IRDiRC Task Force. University of Twente Research Information. 2(2). 9–9. 5 indexed citations
4.
Southall, Noel, Madhusudan Natarajan, Lilian Pek Lian Lau, et al.. (2019). The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force. Orphanet Journal of Rare Diseases. 14(1). 225–225. 19 indexed citations
5.
Derlindati, Eleonora, Luca Marchetti, Valentina Spigoni, et al.. (2017). Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects. PLoS ONE. 12(8). e0182559–e0182559. 20 indexed citations
6.
Boycott, Kym M. & Diego Ardigò. (2017). Addressing challenges in the diagnosis and treatment of rare genetic diseases. Nature Reviews Drug Discovery. 17(3). 151–152. 30 indexed citations
7.
Gaudet, Daniel, Julie Méthot, Diane Brisson, et al.. (2016). A Long-Term (up to 6 years) Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and its Effect on Lipoprotein Lipase Deficiency (LPLD)-Induced Pancreatitis.. Human Gene Therapy. 2 indexed citations
8.
Derlindati, Eleonora, Alessandra Dei, Barbara Montanini, et al.. (2015). Transcriptomic Analysis of Human Polarized Macrophages: More than One Role of Alternative Activation?. PLoS ONE. 10(3). e0119751–e0119751. 57 indexed citations
9.
Dall’Asta, Margherita, Eleonora Derlindati, Diego Ardigò, et al.. (2012). Macrophage polarization: The answer to the diet/inflammation conundrum?. Nutrition Metabolism and Cardiovascular Diseases. 22(5). 387–392. 27 indexed citations
10.
Derlindati, Eleonora, Margherita Dall’Asta, Diego Ardigò, et al.. (2012). Quercetin-3-O-glucuronide affects the gene expression profile of M1 and M2a human macrophages exhibiting anti-inflammatory effects. Food & Function. 3(11). 1144–1144. 43 indexed citations
11.
Franzini, Laura, Diego Ardigò, Silvia Valtueña, et al.. (2010). Food selection based on high total antioxidant capacity improves endothelial function in a low cardiovascular risk population. Nutrition Metabolism and Cardiovascular Diseases. 22(1). 50–57. 67 indexed citations
12.
Fico, Giuseppe, et al.. (2010). A Healthy Lifestyle Coaching-Persuasive Application for Patients with Type 2 Diabetes. PubMed. 25. 2221–2224. 6 indexed citations
13.
Dei, Alessandra, Diego Ardigò, Giuseppe Pedrazzi, et al.. (2010). Reduced Circulating Endothelial Progenitor Cell Number in Young Adult Hyperinsulinemic Healthy Men. Nutrition Metabolism and Cardiovascular Diseases. 1 indexed citations
14.
Ardigò, Diego, Laura Franzini, Silvia Valtueña, et al.. (2009). The increase in plasma PAI-1 associated with insulin resistance may be mediated by the presence of hepatic steatosis. Atherosclerosis. 208(1). 240–245. 9 indexed citations
15.
Valtueña, Silvia, Nicoletta Pellegrini, Laura Franzini, et al.. (2008). Food selection based on total antioxidant capacity can modify antioxidant intake, systemic inflammation, and liver function without altering markers of oxidative stress. American Journal of Clinical Nutrition. 87(5). 1290–1297. 133 indexed citations
16.
Ardigò, Diego, Sandrine Gaillard, & Branko Braam. (2007). Application of leukocyte transcriptomes to assess systemic consequences of risk factors for cardiovascular disease. Clinical Chemistry and Laboratory Medicine (CCLM). 45(9). 1109–20. 13 indexed citations
17.
Valtueña, Silvia, Nicoletta Pellegrini, Diego Ardigò, et al.. (2006). Dietary glycemic index and liver steatosis. American Journal of Clinical Nutrition. 84(1). 136–142. 88 indexed citations
18.
Valtueña, Silvia, Filippo Numeroso, Diego Ardigò, et al.. (2005). Relationship between leptin, insulin, body composition and liver steatosis in non-diabetic moderate drinkers with normal transaminase levels. European Journal of Endocrinology. 153(2). 283–290. 9 indexed citations
19.
Zavaroni, Ivana, Diego Ardigò, A. Zuccarelli, et al.. (2005). Insulin resistance/compensatory hyperinsulinemia predict carotid intimal medial thickness in patients with essential hypertension. Nutrition Metabolism and Cardiovascular Diseases. 16(1). 22–27. 17 indexed citations
20.
Zavaroni, Ivana, Diego Ardigò, P Gasparini, et al.. (2002). Do coronary heart disease risk factors change over time?. Metabolism. 51(8). 1022–1026. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Louis Paul Breakdown of academic impact, for papers by Kyung‐Soo Kim Breakdown of academic impact, for papers by Rosaria Vincenza Giglio Breakdown of academic impact, for papers by Viviane Zorzanelli Rocha Breakdown of academic impact, for papers by Shanil Juma Breakdown of academic impact, for papers by Donatella Siepi Breakdown of academic impact, for papers by Michal Vráblík Breakdown of academic impact, for papers by Parakat Vijayagopal Breakdown of academic impact, for papers by Mariana Floria Breakdown of academic impact, for papers by Manuela Ciocoiu
Rankless by CCL
2026